Both in Pharmaceuticals
Jupiter Neurosciences vs Medicus Pharma
Over the past year JUNS returned −97.7% and MDCX returned −98.4%; their daily moves had a correlation of 0.01.
JUNS −97.7% MDCX −98.4%Growth of $1, one year, split-adjusted
| Metric | JUNS | MDCX |
|---|---|---|
| Price | $2.31 | $1.93 |
| Market cap | $3.0M | $2.8M |
| Today | +12.68% | +2.66% |
| 1 month | −9.4% | −76.0% |
| 6 months | −92.4% | −86.5% |
| Year to date | −97.0% | −97.5% |
| 1 year | −97.8% | −98.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | 86.9% | — |
| Net margin | −9380.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 47.1× | — |
| Net cash | -$6.6K | — |
| Dividend yield | — | — |
| Volatility (60d) | 129.8% | 1,166.4% |
| Short % of float | 6.0% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).